Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Richtand

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Psychiatry|May 3, 2002
What makes a drug a primary mood stabilizer?P E Keck, S L McElroy, N Richtand, et al.
Journal of Neurochemistry|October 1, 1987
Phosphorylation of purified rat striatal tyrosine hydroxylase by Ca2+/calmodulin-dependent protein kinase II: effect of an activator proteinJ Atkinson, N Richtand, C Schworer, et al.
Brain Research|November 8, 1988
MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleusB H Turner, J S Wilson, J C McKenzie, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Psychiatry|May 3, 2002
What makes a drug a primary mood stabilizer?P E Keck, S L McElroy, N Richtand, et al.
Journal of Neurochemistry|October 1, 1987
Phosphorylation of purified rat striatal tyrosine hydroxylase by Ca2+/calmodulin-dependent protein kinase II: effect of an activator proteinJ Atkinson, N Richtand, C Schworer, et al.
Brain Research|November 8, 1988
MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleusB H Turner, J S Wilson, J C McKenzie, et al.
Pageof 1